Scientists propose a new model for Alzheimer’s disease that may explain the high failure rate of recent clinical trials.
During National Alzheimer’s Disease Awareness Month, we look at Scott Small’s newest Alzheimer’s research.
Columbia is part of a new consortium to identify rare genetic variants that may protect against, or contribute to Alzheimer’s disease.
Recent research at Columbia has shed light on an important risk marker for Alzheimer’s—"white matter hyperintensities" (WMH).
Researchers from CUMC, Weill Cornell, and Brandeis have devised a new approach to the treatment of Alzheimer's involving the retromer protein complex.
Dr. Richard Mayeux dispels common misconceptions, and explains the basics, about Alzheimer's disease.